BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 30/09/2021

Microbiological Quality Considerations in Non-Sterile Drug Manufacturing; Draft Guidance for Industry; Availability

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Microbiological Quality Considerations in Non-Sterile Drug Manufacturing." The purpose of this guidance is to assist manufacturers in assuring the microbiological quality of their non- sterile drugs (NSDs). This guidance discusses product development considerations, risk assessments, and certain current good manufacturing practice (CGMP) requirements that are particularly relevant to microbiological control in a manufacturing operation for an NSD.

Source: Federal Register — Food and Drug AdministrationOpen original release →